Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Reexamination Certificate
2006-08-29
2006-08-29
Achutamurthy, Ponnathapura (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
C435S069100, C435S069700
Reexamination Certificate
active
07098015
ABSTRACT:
The invention provides isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27875, 22025, 27420, 16319, 55092 and 10218 gene has been introduced or disrupted. The invention still further provides isolated 27875, 22025, 27420, 17906, 16319, 55092 or 10218 proteins, fusion proteins, antigenic peptides and anti-27875, 22025, 27420, 17906, 16319, 55092 or 10218 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
REFERENCES:
patent: 5527896 (1996-06-01), Wigler et al.
patent: 5702936 (1997-12-01), Beavo et al.
patent: 5798246 (1998-08-01), Au-Young et al.
patent: 5851784 (1998-12-01), Owens et al.
patent: 1 018 559 (2000-07-01), None
patent: WO 91/16457 (1991-10-01), None
Seffernick, J. L., et al., 2001,“Melamine deaminase and atrazine chlorohydroalsase: 98 Percent identical but functionally different”, Journal of Bacteriology, vol. 183, No. 8, pp. 2405-2410.
Sasaki, T et al., “Identification of Human PDE7B, a cAMP-Specific Phosphodiesterase”, Biochemical and Biophysical Research Communications 271(3):575-583 (2000).
Hetman, J. M. et al., “Cloning and Characterization of PDE7B, a cAMP-Specific Phosphodiesterase”, PNAS 97(1):472-476 (2000).
Tamar et al., “Isolation and Characterization of a Previously Undetected Human cAMP Phosphodiesterase by Complementation of cAMP Phosphodiesterase-Deficient Saccharomyces Cerevisiae”, The Journal of Biological Chemistry 268(17):12925-12932 (1993).
ID CN7A—Human, Jun. 1993.
ID CN7A—Mouse, Nov. 1996.
Beavo, “Cyclic Nucleotide Phospholiesterases: Functional Implications of Multiple Isoforms”, Physiological Reviews 75(4) :725-748 (1995).
Bloom et al., “Identification and Tissue-Specific Expression of PDE7 Phosphodiesterase Splice Variants”, PNAS USA 93:14188-14192 (1996).
Han et al., “Alternative Splicing of the High Affinity cAMP-Specific Phosphodiesterase (PCE7A) mmA in Human Skeletal Muscle and Heart”, The Journal of Biological Chemistry 272(26):16152-16157 (1997).
Houslay et al., “Tailoring cAMP-Signalling Responses Through Isoform Multiplicity”, TiBS 22:217-224 (1997).
DNA BLAST Analysis Against NUC, PrevPatent Databases.
Protein BLAST Analysis Against PNU, Patent Databases.
Pitts, William J., et al., “Identification of Purine Inhibitors of Phosphodiesterase 7 (PDE7)”, Bioorganic & Medicinal Chemistry Letters 14:2955-2958 (2004).
Gardner, Clare et al., “Cloning and Characterization of the Human and Mouse PDE7B, a Novel cAMP-Specific Cyclic Nucleotide Phosphodiesterase”, Biochemical and Biophysical Research Communications 272:186-192 (2000).
Carroll Joseph M.
Chun Miyoung
Cook William James
MacBeth Kyle J.
Meyers Rachel E.
Achutamurthy Ponnathapura
Millennium Pharmaceuticals Inc.
Millennium Pharmaceuticals Inc.
Moore William W.
LandOfFree
27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701887